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1. Introduction   
Phenolic amino acids represent a wide class of compounds 
endowed with interesting biological activities. The natural 
phenolic amino acid, tyrosine displays antioxidant 
properties,1 performing vital antioxidant functions inside 
lipid bilayers and protecting cells from oxidative destruction.2 
Non-proteinogenic phenolic amino acids are crucial 
components of certain peptidic natural products such as the 
vancomycin group of antibiotics3 (4-hydroxyphenylglycine) 
and of cell-penetrating peptides (CPPs).4 CPPs are short, 
nontoxic peptides containing cationic and non-coded 
hydrophobic amino acids that can carry small molecules. 
They are able to cross, not only the cellular membrane, but 
also to target inside specific cellular organelles such as 
nucleus and mitochondria. Of the CPPs tested as 
mitochondria targeted antioxidants5. the Szeto-Schiller (SS) 
peptides are the most promising.6 There are a number of 
surprising features about these peptides. Despite being water 
soluble, with a net charge of 3+, they are readily taken up by 
all cells via passive diffusion.7-9 The presence of a D-amino 
acid and non-coded amino acids at the tips of the peptide 
renders them resistant to aminopeptidase activity. The 
mechanism behind their cell permeability is unclear, but the 
aromatic rings may serve as electron cages to shield the 
cationic charges via cation-π interaction. These SS peptides 
may be viewed as “cloaked” or “stealth” as they can evade 
cellular membranes, even penetrating cell barriers with tight 
junctions including the blood-brain barrier.7,10 The 
antioxidant action of SS peptides in scavenging radical 
oxygen species and inhibiting low density lipoprotein 
oxidation, is attributed to the 2,5-dimethyl-L-tyrosine 
residue.  
The ortho-dihydroxyaryl function present in catechols gives 
compounds with a broad scope of properties that confer 
important biochemical functions.11 Such properties result 
from; the ability to establish reversible equilibria at moderate 
redox potentials and pHs; irreversible cross-linking through 
complex oxidation mechanisms; excellent chelating 
properties; interaction of the vicinal hydroxyl groups with 
surfaces of different nature. Despite these properties, little 
attention has been given to amino acids with the ortho-
dihydroxyaryl function, such as 3,4-dihydroxyphenylglycine. 
This non-natural amino acid has been studied as copper 
ligand12 and as a substrate for tyrosinase, being converted to 
3,4-dihydroxybenzaldehyde via spontaneous decarboxylation 
of the enzymatically generated ortho-quinone.13 
Amino acids coupled with phenolic or catecholic groups are 
bioactive substances involved in suppression of deleterious 
effects of oxidative stress14-17 and have a wide range of 
biological activities such as anti-atherogenic,18 anticancer19 
and antimicrobial.20-23 Studies have confirmed that 
conjugation between different types of compounds such as 
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A simple and efficient procedure for the synthesis of N-acyl 4-hydroxy, 4-hydroxy-3-methoxy and 
3,4-dihydroxy phenylglycine amides by a strategy based on the multicomponent Ugi reaction is 
proposed. Hydroxybenzaldehyde derivatives were reacted with 4-methoxybenzylamine, 
cyclohexyl isocyanide and benzoic acid or 2-naphthylacetic acid to give Ugi adducts that were 
treated with trifluoroacetic acid yielding N-acyl hydroxyphenylglycine amides in good yields. The 
same procedure using as acid component protocatechuic acid or hydrocaffeic acid gave N-
catechoyl 3,4-dihydroxyphenylglycine amides. The use of N-benzyloxycarbonylglycine as acid 
component allowed the preparation of a 3,4-dihydroxyphenylglycyl dipeptide derivative. Radical-
scavenging activity studies of the polyphenolic amino acid derivatives showed a sharp increase in 
activity with the increase in number of hydroxyl or catechol groups present. Cyclic voltammetry 
experiments established a correlation between oxidation peak potentials and the radical-
scavenging activity. 
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amino acids and phenolic acids is useful, not only to 
investigate structure activity relationships, but can also 
constitute a strategy to improve antioxidant efficiency and 
bioactivity.24,25 Recently, we established an innovative 
synthetic strategy that allowed the preparation of a library of 
N-phenolic and N-catecholic dehydroamino acid 
derivatives.26   
The development of synthetic strategies that allow the 
synthesis of new amino acids with phenolic or catecholic side 
chains and conjugates of these amino acid with phenolic or 
cathecolic groups would give rise to a new repertoire of 
interesting synthetic building blocks. These may have a wide 
application in the preparation, not only of specific cellular 
organelle targeted antioxidant peptides,5 but can also have 
other intrinsic biological activities or broader applications, 
such as: cross-linkers with proteins or carbohydrates;27 
transition metal ligands;28 or used in the design of new 
peptide hydrogels that mimic mussel adhesive proteins.29-32 
 
2. Results and Discussion   
A simple approach to obtain new hydroxyphenylglycines 
and/or conjugates of hydroxyphenylglycines with phenolic or 
catecholic acids would be a strategy where simple natural 
phenols are joined together in a one-step economical way. 
One such multicomponent reaction is the Ugi reaction, first 
reported by Ivar Ugi.33,34 It is classified as an isocyanide-
based multicomponent reaction, consisting of the 
simultaneous joining of 4 different classes of compounds: an 
aldehyde; a carboxylic acid; an amine and an isocyanide. 
Lambruschini et al.35 using the Ugi reaction, were able to 
prepare a series of complex polyphenols containing two to 
four hydroxy-substituted aryl groups. This methodology, 
using hydroxyl substituted benzoic acids and benzaldehydes, 
gave hydroxylated bis-amides and their effect on quenching 
radicals and DNA oxidation was estimated.36 However, 
derivatives with the ortho-catechol moiety as the amino acid 
side chain have not been report.  
A strategy based on the modified Ugi reaction, using as amine 
component 4-methoxybenzylamine and as isocyanide the 
commercially available and relatively stable cyclohexyl 
isocyanide, followed by treatment of the adducts with 
trifluoroacetic acid (TFA) has previously been explored.37,38 
This procedure using as aldehyde component phenolic or 
catecholic benzyladehydes and as acid component catecholic 
acids, could be an efficient approach for the synthesis of 
novel N-(catechoyl)-hydroxy and 3,4-dihydroxy 
phenylglycines. Thus, a strategy based on the modified Ugi 
reaction using phenolic and/or catecholic benzaldehydes and 
carboxylic acid components was explored.  
A severe limitation of the application of ortho-catechol 
moieties in synthesis is their high instability in basic 
environment. Thus, due to the basic nature of the amine 
component, protection of the hydroxyl function of the 
benzaldehyde would be required. O-tert-
Butyloxycarbonylated benzaldehydes can be easily obtained 
by reaction of hydroxybenzaldehydes with tert-
butyldicarbonate in the presence of dimethylaminopyridine 
as catalyst.26 Furthermore, this temporary protection can be 
removed in the subsequent treatment with TFA, a reagent 
generally used in peptide synthesis to remove acid-labile 
protecting groups.39,40 
A preliminary test was carried out using as reactants tert-
butyl (4-formylphenyl) carbonate, 4-methoxybenzylamine, 
benzoic acid and cyclohexyl isocyanide in a 1/1 solution of 
ethanol and trifluorethanol (TFE) to give compound 1a' in 
high yield (Scheme 1). The proton NMR spectrum of the 
compound gave the expected peaks with the diastereotopic 
CH2 protons of the benzylamine group appearing as two 
signals at 4.41 ppm and 4.63 ppm. The Ugi adduct was treated 
with TFA at 80 °C for 10 min. Removal of TFA gave an oily 
residue that precipitated on addition of diethyl ether to give 
N-benzoyl, 4-hydroxyphenylglycine cyclohexylamide in 





Scheme 1 Synthesis of Ugi adducts and treatment with trifluoroacetic acid to give N-acyl hydroxyphenylglycine cyclohexylamides. 
 
Treatment of Ugi adduct 1a' with TFA allowed the 
simultaneous removal of the methoxybenzyl and the tert-
butyloxycarbonyl groups, without affecting the 
cyclohexylamide. This is in agreement with previous results 
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by Maia et al. in the synthesis of N-acyl--dialkylglycines 
by cleavage of Ugi adducts with neat TFA.38 Treatment in 
these conditions of N-benzoyl-N,α,α-trialkylglycine amides 
formed by reaction of 4-methoxybenzylamine, benzoic acid, 
cyclohexyl isocyanide and the more bulky dibenzylketone, 
resulted in removal of the methoxybenzyl group without 
amide cleavage. The authors reported that in neat TFA the N-
alkyl group of the bulkier N-benzoyl, N-(4-methoxybenzyl) 
α,α-dibenzylglycine derivatives cleaves faster than their 
amide bond. They concluded that for acidolytic cleavage of 
the C-terminal amide to occur, the presence of an alkyl/aryl 
substituent at the amino acid nitrogen atom is required. Thus, 
the phenyl group directly linked to the -carbon in adduct 1a' 
seems to exert a steric effect comparable to that reported for 
the -dibenzyl moiety in N-acyl-N,α,α-trialkylglycine 
amides. 
Compound 1a could also be obtained in a one-pot procedure 
consisting of the condensation reaction, followed by 
evaporation of the solvent at reduced pressure and treatment 
of the residue with TFA (Scheme 1). tert-Butyl (4-formyl-2-
methoxyphenyl) carbonate and di-tert-butyl (4-formyl-1,2-
phenylene) dicarbonate (Scheme 1, compounds b and c, 
respectively) were reacted in this one-pot procedure to give 
N-benzoyl, 4-hydroxy-3-methoxy and N-benzoyl, 3,4-
dihydroxy phenylglycine cyclohexylamides in 76% and 66% 
yields, respectively (compounds 1b and 1c). An attempt to 
carry out the condensation reaction using the highly sterically 
hindered di-tert-butyl (3-formyl-1,2-phenylene) dicarbonate 
(compound d) and benzoic acid gave only trace amounts of 
the corresponding Ugi adduct (compound 1d').   
The reaction was carried out substituting 2-naphthylacetic 
acid for benzoic acid and using di-tert-butyl (4-formyl-1,2-
phenylene) dicarbonate to give the N-(2-naphthyl)acetyl, 3,4-
dihydroxyphenylglycine amide in 78% yield (compound 2c, 
Scheme 1). 
The results obtained led us to explore the possibility of using 
catecholic acids as acid component in the Ugi reaction, 
namely, protocatechuic and hydrocaffeic acid. These 
cathecolic acids were tested without hydroxyl protection 
since, when the acid component is added, all 4-
methoxybenzylamine has been consumed. Thus, tert-butyl 
(4-formylphenyl) carbonate was reacted in the same 
conditions, substituting protocatechuic acid for benzoic acid 
to give the Ugi adduct 3a' in quantitative yield (Scheme 1). 
Treatment of compound 3a' with TFA gave the N-
protocatechoyl 4-hydroxyphenylglycine derivative in 72% 
yield (compound 3a). By reacting tert-butyl (4-formyl-2-
methoxyphenyl) carbonate or di-tert-butyl (4-formyl-1,2-
phenylene) dicarbonate with protocatechuic acid, the 
corresponding N-protocatechoyl, hydroxyphenylglycine 
amides were obtained in good yields (compounds 3b and 3c, 
respectively). The reaction using hydrocaffeic acid and di-
tert-butyl (4-formyl-1,2-phenylene) dicarbonate gave 
compound 4c in 74% yield. Thus, the use of di-tert-butyl (4-
formyl-1,2-phenylene) dicarbonate and protocatechuic or 
hydrocaffeic acid, allows the synthesis of amino acid 
derivatives baring two catecholic groups. 
Synthesis of compound 4c shows that the steric effect of the 
phenyl group linked to the -carbon induces removal of the 
methoxybenzyl group without amide cleavage, even with the 
less sterically hindered hydrocaffeoyl substituent as N-acyl 
group. This was further confirmed by reacting tert-butyl (4-
formylphenyl) carbonate with acetic acid as carboxylic 
component. Again, treatment of the Ugi adduct with neat 
TFA led to removal of the methoxybenzyl group without 
amide cleavage (compound 5a).  
The procedure was also carried out using as acid component 
a N-protected amino acid, namely, N-
benzyloxycarbonylglycine. A Ugi adduct was obtained 
(compound 6c', Scheme 2) which, after treatment with TFA 
gave a 3,4-dihydroxyphenylglycyl dipeptide derivative in 
74% yield (compound 6c, Scheme 2). Thus, the methodology 
developed also allows the preparation of 
hydroxyphenylglycyl dipeptide derivatives. 
Scheme 2 Synthesis of a 3,4-dihydroxyphenylglycyl dipeptide 
derivative. 
In order to establish the antioxidant capacity of the N-acyl 
hydroxyphenylglycines prepared, the radical-scavenging 
activity of selected compounds was determined using 1,1-
diphenyl-2-picrylhydrazyl (DPPH•) as a stable radical.41 The 
EC50 values (relative concentration of antioxidant required to 
lower the initial DPPH• concentration by 50%) were 
determined after several reaction times and compared to the 
values obtained for protocatechuic acid (Table 1). As 
expected, the radical-scavenging activity against the DPPH 
radical of the monophenol derivative 1a was very weak. 
However, a significant increase in activity occurs when a 
methoxy group is added in ortho position to the hydroxyl 
group (compound 1b) (a six-fold increase for EC50 
determined after 5 minutes). The substitution of this methoxy 
group by another hydroxyl group (compound 1c), increases 
more than ten times the radical-scavenging activity. A 
slightly higher activity is observed when (2-naphthyl)acetyl 
is substituted for benzoyl as N-acyl group (compound 2c). 
The N-protocatechoyl 4-hydroxylphenylglycine derivatives 
(compound 3a) showed radical-scavenging activity 
comparable to that of compound 1c, which also has an ortho-
dihydroxyaryl function as amino acid side chain. Introduction 
of a methoxy group in ortho position to the hydroxyl group 
(compound 3b) causes a 25% increases in activity as 
determined after 5 minutes. Substitution of the methoxy 
group with a second hydroxyl group (compound 3c) causes a 
further 30% increase in activity. The N-hydrocaffeoyl 3,4-
dihydroxyphenylglycine derivative (compound 4c) showed 
similar activity to the N-protocatechoyl derivative 3c. Thus, 
the radical-scavenging activities of compounds 3c and 4c 
were almost double the activities of derivatives with a single 
catecholic group (compounds 1c or 3a).  
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These results show a direct correlation between radical-
scavenging capacity against the DPPH radical and the 
number of hydroxyl or catechol groups present in the 
phenylglycine derivatives. A high increase in activity with the 
increase in number of hydroxyl or catechol groups is 
observed with the monocatecholic derivatives (compounds 1c 
and 3a) having twice the radical-scavenging activity of 
protocatechuic acid, while the N-catechoyl derivatives 3c and 
4c have almost four times this activity. Thus, the introduction 
of the catecholic moiety in an amino acid structure induces a 
significant increase in its intrinsic radical scavenging activity. 
 
Table 1 DPPH• Radical-scavenging capacity, EC50a, oxidation peak potentials and Log Pb of N-acyl 4-hydroxy, 4-
hydroxy-3-methoxy and 3,4-dihydroxy phenylglycine cyclohexylamides and of protocatechuic acid and tyrosine. 
 
 
Compound R1 R2 
EC50 Ep,a 
(V vs Ag/AgCl) 
Log P 












0.32 ± 0.01 0.22 ± 0.01 0.272 ± 0.006 2.76 
2c  
 




0.37 ± 0.01 0.23 ± 0.01 0.274 ± 0.003 2.28 
3b 
  








0.19  ±  0.01 0.16 ± 0.01 0.145 ± 0.008 




 0.69 ± 0.03 0.31 ± 0.01 0.324 ± 0.005 0.88 
Tyrosine 
 
26.5 ± 11.70 nd 0,715± 0.018 -2.20 
aThe antiradical activity was defined as the relative concentration of antioxidant required to lower the initial DPPH• concentration by 50% 
[EC50 (M phenolic compound per unit DPPH concentration)] obtained at different reaction times. 
 bPartition coefficient between water and n-octanol. Estimated using Molinspiration Cheminformatics software (Molinspiration, Slovensky 
Grob, Slovak Republic, 2017, http://www.molinspiration.com). 
 
 
Correlation between antioxidant profile and redox 
properties of low molecular weight antioxidants is well 
established.42 Cyclic voltammetry has been used as an 
important tool for the evaluation of antioxidant capacity of 
this type of antioxidants. Compounds with lower oxidation 
potentials are more readily oxidized and usually show 
better antioxidant activities. Thus, oxidation peak 
potentials for the hydroxyphenylglycine derivatives were 
determined by cyclic voltammetry using a glassy carbon 
working electrode and measured vs a Ag/AgCl electrode 
(Table 1). Experiments were run using as supporting 
electrolyte a phosphate buffer at the physiological pH of 
7.30.  
Compound 1a, which showed very weak radical-
scavenging activity, presented the highest oxidation peak 
potential (0.703 V). A decrease in over 0.2 V in potential 
occurs when a methoxy group is added in ortho position to 
the hydroxyl group (compound 1b) in agreement with a 
significant increase in radical-scavenging activity against 
the DPPH radical. The substitution of the methoxy group 
by a second hydroxyl group (compound 1c) causes a 
further significant decrease in the oxidation potential 
(0.228 V), which also agrees with the ten-fold increase 
observed in radical-scavenging activity. Compounds with 
a single catecholic group (compounds 2c, 3a and 3b) gave 
anodic peaks with similar potentials ca. 0.270 V, that 
corresponded to similar radical-scavenging activities. 
These potentials were lower than the peak potential for the 
catecholic reference protocatechuic acid (0.324 V). 
Compound 3c baring two similar catecholic groups gave 
only one anodic peak at a similar potential to the other 
catecholic compounds (0.272 V). Thus, the increase in 
radical-scavenging activity of compound 3c, when 




compounds, must result from an additive effect of the two 
catechol groups.   
On the other hand, two anodic peaks were observed for 
compound 4c, one at 0.145 V and another at 0.233 V. The 
first peak probably results from oxidation of the N-
hydrocaffeoyl group, since the potential of this peak was 
similar to that determined by us for octyl hydrocaffeate 
(0.145 V, data not shown). The potential of the second 
peak, although slightly lower, is in line with the peak 
potentials presented by the other glycine derivatives with 
an ortho-dihydroxyaryl side chain (compounds 1c, 2c and 
3c). Despite the lower oxidation potential of the first peak, 
compound 4c did not present higher radical-scavenging 
activity against the DPPH radical than compound 3c, 
which also has catecholic groups both as N-acyl and as side 
chain moiety. 
These cyclic voltammetry experiments indicate a 
significant decrease in oxidation potential with the increase 
in number of hydroxyl groups. Thus, a correlation between 
oxidation potentials and radical-scavenging activity can be 
established, with lower oxidation potentials corresponding 
to higher radical-scavenging activities. 
Despite the increase in the number of hydroxyl groups in 
these non-coded amino acid, their log P is significantly 
higher (Table 1) than that for tyrosine. This probably 




A simple and efficient one-pot procedure for the synthesis 
of N-acyl hydroxyphenylglycine amides has been 
established. These novel hydroxyphenylglycine 
derivatives, in particular the polyphenolic amino acids N-
protocatechoyl and N-hydrocaffeoyl 3,4-
dihydroxyphenylglycine amides exhibited high radical-
scavenging activity.  
The synthesis of the N-benzyloxycarbonyl-3,4-
dihydroxyphenylglycyl dipeptide derivative shows that the 
methodology developed gives rise to a substrate that, after 
N-acyl deprotection, can be coupled with other amino acid 
residues to give, among others, cell-penetrating type 
peptides that can be tested as mitochondria targeted 
antioxidants. 
In addition, these non-coded amino acid derivatives can 
have other intrinsic biological activities or be applied as: 
cross-linkers; transition metal ligands; or used in the design 
of new peptide hydrogels.  
4. Experimental Section 
4.1. General methods 
Melting points (°C) were determined in a Gallenkamp 
apparatus and are uncorrected. 1H and 13C NMR spectra 
were recorded on a Bruker Avance II+ instrument. Spectra 
were taken at room temperature in CDCl3, CD3COCD3 and 
CD3OD at 400 MHz (1H) and 100.6 MHz (13C) by using 
TMS as an internal standard (1H NMR in CDCl3: 0.000 
ppm). 1H-1H spin-spin decoupling, DEPT 45°, HMQC 
and HMBC were used to attribute some signals. Chemical 
shifts are given in ppm and coupling constants in Hz. 
HRMS data were recorded by the Laboratory for Structural 
Elucidation of the Materials Centre of the University of 
Porto on an LTQ OrbitrapTM XL hybrid mass spectrometer 
(Thermo Fischer Scientific, Bremen, Germany) controlled 
by LTQ Tune Plus 2.5.5 and Xcalibur 2.1.0. Elemental 
analysis was performed on a LECO CHNS 932 elemental 
analyzer. The reactions were monitored by thin layer 
chromatography (TLC). Column chromatography was 
performed on Macherey-Nagel silica gel 230-400 mesh. 
Petroleum ether refers to the boiling range 40-60 °C. 
Solvents were used without purification except for 
acetonitrile which was dried using standard procedures.  
4.1.1.  DPPH •  Radical  Essay  
DPPH• radical-scavenging activity was assessed as 
described previously.41,43 Methanolic DPPH• stock 
solution (1.93 mM) was diluted to give a 0.10 mM working 
solution. The reaction between DPPH• and each 
antioxidant was monitored at 515 nm by using a 
Powerwave XS Microplate Reader (Bio-Tek Instruments, 
Inc) thermostated at T = 25.0 ± 0.1 °C. The wells of a 96-
well microplate contained a methanolic solution of the 
antioxidant (3-200 µM) and 80 µM DPPH•. The 
absorbance of each well was recorded at 1 min. intervals 
for a 60 min. period. The absorbance of each solution was 
subtracted from the blank (80 µM DPPH• without 
antioxidant). The antiradical activity was defined as the 
relative concentration of antioxidant required to lower the 
initial DPPH• concentration by 50% [EC50 (mol/L phenolic 
compound per unit DPPH concentration)]. 
4.1.2.  Cyclic  vol tammetry  
The cyclic voltammetry experiments were carried out 
using a Hi-Tek potentiostat, type DT 2101, and a Hi-Tek 
wave generator type PPRl, connected to a Philips recorder, 
type PM 8043, and to a three electrode, home-built glass 
cell. The working electrode was a vitreous carbon disc 
(diameter: 3 mm), the counter electrode a platinum spiral 
and the reference electrode a mercury pool. The supporting 
electrolyte was a phosphate buffer (0.10 M) with pH 
adjusted to 7.30. Stock solutions of each compound (0.01 
M) were prepared by dissolving an appropriate amount in 
ethanol. The voltammetric working solutions were 
prepared in the electrochemical cell by diluting 0.10 mL of 
the stock solution in 10 mL of supporting electrolyte in 
order to obtain a final concentration of 0.0001 M. At the 
end of each experiment the potential of the mercury pool 
was measured vs a Ag/AgCl electrode. Between 
experiments the working electrode was repolished with 
alumina powder (~0.05 m). 
4.1.3.  Stat is t ical  analys is  
All the DPPH• radical scavenging assays and cyclic 
voltammetry experiments were run at least in 
quadruplicate. SPSS 21.0 software was used for statistical 
analysis by one-way analysis of variance (ANOVA, with 




significance set at P < 0.05. Data are presented as means  
standard deviation. 
4.2. Synthesis 
Procedure A: Synthesis of O-tert-butyloxycarbonylated 
benzaldehydes. To a solution of the hydroxybenzaldehyde 
(5.00 mmol) in dry acetonitrile (0.20 M), 0.10 equiv of 
dimethylaminopyridine was added. This was followed by 
addition under rapid stirring at room temperature of 1.10 
equiv of tert-butyldicarbonate for the monohydroxylated 
benzaldehydes and 2.20 equiv for the dihydroxylated 
benzaldehyde. When all the reactant had been fully tert-
butyloxycarbonylated the solvent was evaporated at 
reduced pressure and the residue was dissolved in ethyl 
acetate (100 mL) and washed with KHSO4 (1 M) and brine 
(3 times 25 mL each). The organic layer was dried with 
MgSO4 and the solvent evaporated at reduced pressure. 
The product obtained was then recrystallized or subject to 
column chromatography. 
tert-Butyl (4-formylphenyl) carbonate (a).44 Procedure 
A using 4-hydroxybenzaldehyde (0.611 g, 5.000 mmol) 
was followed to give a. 
Yield: 1.066 g (96%); white solid (from diethyl ether/n-
hexane). The spectroscopic properties were in agreement 
with those previously reported.44 
tert-Butyl (4-formyl-2-methoxyphenyl) carbonate (b).45 
Procedure A using 4-hydroxy-3-methoxybenzaldehyde 
(0.761 g, 5.000 mmol) was followed to give b. 
Yield: 1.197 g (95%); white solid (from diethyl ether/n-
hexane). The spectroscopic properties were in agreement 
with those previously reported.45 
 
di-tert-Butyl (4-formyl-1,2-phenylene) dicarbonate 
(c).46 Procedure A using 3,4-dihydroxybenzaldehyde 
(0.691 g, 5.000 mmol) was followed to give c. 
Yield: 1.575 g (93%); light brown oil. The spectroscopic 
properties were in agreement with those previously 
reported.46 
 
di-tert-Butyl (3-formyl-1,2-phenylene) dicarbonate (d). 
Procedure A using 2,3-dihydroxybenzaldehyde (0.691 g, 
5.000 mmol) was followed to give d. 
Yield: 1.622 g (96%); light brown solid. 
Rf = 0.43 (petroleum ether/diethyl ether 1:1). 
M.p. 58-59 °C. 
1H NMR (400 MHz, CDCl3): δ = 1.56 [s, 18H, 2C(CH3)3], 
7.36-7.40 (m, 1H, ArH), 7.53 (dd, J = 8.0 Hz, J = 1.6 Hz, 
1H, ArH), 7.75 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H, ArH), 10.19 
(s, 1H, CHO) ppm.  
13C NMR (100.6 MHz, CDCl3): δ = 27.11 [C(CH3)3], 27.14 
[C(CH3)3], 83.94 [C(CH3)3], 84.37 [C(CH3)3], 126.07 
(CH), 126.39 (CH), 128.53 (CH), 129.35 (C), 143.08 (C), 
143.74 (C) 149.67 (C=O), 149.99 (C=O), 187.27 (CH=O) 
ppm. 
HRMS (ESI): m/z M+ calcd for C17H22O7: 338.1366; 
found: 338.1597. 
 
Procedure B: Two step synthesis of N-acyl, 
hydroxyphenylglycine cyclohexylamides. To a solution 
of the O-tert-butyloxycarbonylated benzaldehyde 
(1.00 mmol) in ethanol/2,2,2-trifluoroethanol (1/1) (0.17  
M) under a stream of nitrogen, 1.10 equiv of 4-
methoxybenzylamine was added. After 4 hours, 1.10 equiv 
of the carboxylic acid and 1.10 equiv of cyclohexyl 
isocyanide were added and left to react for 2 days. The 
reaction mixture was then evaporated at reduced pressure 
and the residue was dissolved in ethyl acetate (100 mL) and 
washed with KHSO4 (1 M), NaHCO3 (1 M) and brine (3 
times 25 mL each). The organic layer was dried with 
MgSO4 and the solvent evaporated at reduced pressure to 
give the corresponding Ugi adduct. Trifluoroacetic acid 
was added to the adduct (0.25 M) and the solution refluxed 
at 80 °C for 10 min. TFA was then evaporated at reduced 
pressure. The product obtained was then recrystallized or 
subject to column chromatography. 
N-Benzoyl, (4-hydroxyphenyl)glycine cyclohexylamide 
(1a). Procedure B using tert-butyl (4-formylphenyl) 
carbonate (0.222 g, 1.000 mmol) and benzoic acid was 
followed to give 1a'. 
Yield: 0.537 g (94%); white solid (from diethyl ether).  
Rf = 0.68 (petroleum ether/diethyl ether 1:5). 
M.p. 65-66 °C.  
1H NMR (400 MHz, CDCl3): δ = 0.86-1.93 (m, 10H, CH2 
cyclohexyl), 1.57 [s, 9H, C(CH3)3], 3.76 (s, 3H, OCH3), 
3.79-3.82 (m, 1H, CH cyclohexyl), 4.41 (br. s, 1H, 
C6H4CH2), 4.63 (br. s, 1H, C6H4CH2), 5.40 (br. s, 1H, 
CH), 5.74 (br. s, 1H, NH), 6.74 (d, J = 8.4 Hz, 2H, ArH), 
7.00 (br. d, J = 4.8 Hz, 2H, ArH), 7.13 (d, J = 8.8 Hz, 2H, 
ArH), 7.35-7.37 (m, 4H, ArH), 7.46-7.49 (m, 3H, ArH) 
ppm.  
13C NMR (100.6 MHz, CDCl3): δ = 24.70 (CH2), 24.78 
(CH2), 25.44 (CH2), 27.66 [C(CH3)3], 32.69 (2CH2), 48.64 
(CH cyclohexyl), 55.20 (OCH3), 64.08 (CH), 65.82 
(C6H4CH2), 83.80 [C(CH3)3], 113.87 (3CH), 121.61 
(3CH), 126.68 (CH), 128.38 (CH), 128.49 (CH), 129.84 
(CH), 130.07 (CH), 130.70 (CH), 132.65 (2C), 133.35 
(CH), 136.08 (C), 151.08 (C), 151.54 (C), 158.76 (C=O), 
168.04 (C=O), 173.07 (C=O) ppm.  
Anal. calcd. for C34H40N2O6 (572.69): C 71.31, H 7.04, N 
4.89; found C 71.39, H 7.32, H 4.51.  
Trifluoroacetic acid was added to 1a' (0.307 g, 
0.537 mmol) (0.25 M) and the solution refluxed at 80 °C 
for 10 min. TFA was then evaporated at reduced pressure 
to give 1a.  
Yield: 0.118 g (63%); white solid (from diethyl ether).  
Rf = 0.48 (petroleum ether/diethyl ether 1:5). 
M.p. 141-142 °C.  
1H NMR (400 MHz, CD3COCD3): δ = 1.14-1.36 (m, 5H, 
CH2 cyclohexyl), 1.57-2.12 (m, 5H, CH2 cyclohexyl), 
3.68-3.76 (m, 1H, CH cyclohexyl), 5.64 (s, 1H, CH), 6.82 
(d, J = 8.4 Hz, 2H, ArH), 7.37 (d, J = 8.4 Hz, 2H, ArH), 
7.46-7.50 (m, 2H, ArH), 7.53-7.57 (m, 1H, ArH), 7.93-
7.95 (m, 2H, ArH) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 25.48 (CH2), 
25.57 (CH2), 26.22 (CH2), 33.21 (CH2), 33.30 (CH2), 49.10 
(CH cyclohexyl), 57.27 (CH), 115.91 (2CH), 128.08 
(2CH), 129.17 (2CH), 129.58 (2H), 131.04 (C), 132.13 
(CH), 135.40 (C), 157.83 (C), 166.36 (C=O), 170.12 




HRMS (ESI): m/z [M + H]+ calcd for C21H25N2O3: 
353.1865; found: 353.1856. 
 
Tentative synthesis of N-benzoyl, (2,3-
dihydroxyphenyl)glycine cyclohexylamide (1d). 
Procedure B using di-tert-butyl (3-formyl-1,2-phenylene) 
dicarbonate (0.338 g, 1.000 mmol) and benzoic acid was 
followed. The residue obtained was chromatographed 
through silica using as eluent ethyl acetate/petroleum ether 
1:3 to give the Ugi adduct 1d' in low yield.  
Yield: 0.116 g (17%); light yellow oil. 
Rf = 0.64 (petroleum ether/diethyl ether 1:5). 
1H NMR (400 MHz, CDCl3): δ = 1.15-1.96 (m, 10H, CH2 
cyclohexyl), 1.46, 1.57, 1.76 [s, 18H, C(CH3)3], 3.79 (br. s, 
4H, OCH3 + CH cyclohexyl), 4.25 (d, J = 4.8 Hz, 2H, 
C6H4CH2), 4.80 (br. s, 1H, CH), 5.92 (br. d, J = 7.6 Hz, 
1H, NH), 6.86 (d, J = 8.8 Hz, 2H, ArH), 6.94 (t, J = 8.0 Hz, 
1H, ArH), 7.14 (dd, J = 8.0 Hz, J = 1.6 Hz, 1H, ArH), 7.18-
7.22 (m, 3H, ArH), 7.47 (t, J = 8.0 Hz, 2H, ArH), 7.59 (t, J 
= 7.2 Hz, 1H, ArH), 8.01 (dd, J = 8.0 Hz, J = 1.2 Hz, 2H, 
ArH) ppm.  
13C NMR (100.6 MHz, CDCl3): δ = 24.59 (CH2), 24.69 
(CH2), 25.47 (CH2), 27.57 [C(CH3)3], 28.38 [C(CH3)3], 
32.91 (2CH2), 48.06 (CH cyclohexyl), 55.26 (OCH3), 
58.43 (C6H4CH2), 82.02 [2C(CH3)3], 113.96 (2CH), 
119.46 (CH), 120.20 (CH), 120.56 (C), 121.56 (CH), 
124.29 (CH), 128.49 (2CH), 128.79 (CH), 129.49 (2CH), 
129.62 (C), 130.51 (C), 130.87 (CH), 130.94 (C), 130.97 
(C), 133.18 (CH), 144.88 (C), 158.89 (2C=O), 168.82 
(C=O), 172.00 (C=O) ppm.  




cyclohexylamide (3a). Procedure B using tert-butyl (4-
formylphenyl) carbonate (0.444 g, 2.000 mmol) and 
protocatechuic acid was followed to give 3a'. 
Yield: 1.208 g (quantitative); colourless oil.  
Rf = 0.31 (petroleum ether/diethyl ether 1:5). 
M.p. 119-120 °C.  
1H NMR (400 MHz, CDCl3): δ = 1.03-1.86 (m, 10H, CH2 
cyclohexyl), 1.57 [s, 9H, C(CH3)3], 3.72-3.75 (m, 4H, 
OCH3 + CH cyclohexyl), 4.39 (br. s, 1H, C6H4CH2), 4.76 
(br. s, 1H, C6H4CH2), 5.16 (br. s, 1H, CH), 5.81 (br. s, 
1H, NH), 6.72-6.79 (m, 3H, ArH), 6.89 (br. d, J = 8.4 Hz, 
1H, ArH), 7.00-7.02 (m, 2H, ArH), 7.10-7.12 (m, 3H, 
ArH), 7.32 (br. d, J = 8.4 Hz, 2H, ArH) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 24.60 (CH2), 
24.66 (CH2), 25.32 (CH2), 27.67 [C(CH3)3], 32.46 (2CH2), 
48.94 (CH cyclohexyl), 55.21 (OCH3), 60.40 (CH), 83.89 
[C(CH3)3], 113.96 (3CH), 114.86 (CH), 115.05 (CH), 
119.67 (CH), 121.70 (3CH), 126.75 (C), 128.68 (CH), 
130.03 (C), 130.60 (CH), 132.22 (C), 144.34 (C), 147.07 
(C), 151.18 (C), 151.55 (C), 158.87 (C=O), 168.84 (C=O), 
171.18 (C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C34H41N2O8: 
605.2863; found: 605.2856. 
Trifluoroacetic acid was added to 3a' (0.453 g, 
0.750 mmol) (0.25 M) and the solution refluxed at 80 °C 
for 10 min. TFA was then evaporated at reduced pressure. 
The residue was dissolved in ethyl acetate (100 mL) and 
washed with KHSO4 (1 M), NaHCO3 (1 M) and brine (3 
times 25 mL each). The organic layer was dried with 
MgSO4 and the solvent evaporated at reduced pressure to 
give 3a.  
Yield: 0.207 g (72%); white solid (from ethyl 
acetate/dichloromethane).  
Rf = 0.90 (petroleum ether/ethyl acetate 1:4). 
M.p. 158-159 °C.  
1H NMR (400 MHz, CD3COCD3): δ = 1.11-1.39 (m, 5H, 
CH2 cyclohexyl), 1.57-1.78 (m, 4H, CH2 cyclohexyl), 
1.87-1.90 (m, 1H, CH2 cyclohexyl), 3.69-3.75 (m, 1H, CH 
cyclohexyl), 5.60 (d, J = 7.6 Hz, 1H, CH), 6.80-6.82 (m, 
2H, ArH), 6.89 (d, J = 8.0 Hz, 1H, ArH), 7.34-7.36 (m, 3H, 
ArH), 7.46 (d, J = 2.0 Hz, 1H, ArH), 7.75 (d, J = 7.6 Hz, 
1H, NH), 8.42 (br. s, 3H, OH) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 25.48 (CH2), 
25.56 (CH2), 26.21 (CH2), 33.22 (CH2), 33.29 (CH2), 49.21 
(CH cyclohexyl), 57.29 (CH), 115.50 (CH), 115.61 (CH), 
115.92 (2CH), 120.38 (CH), 127.16 (C), 129.53 (2CH), 
131.30 (C), 145.60 (C), 149.20 (C), 157.79 (C), 166.23 
(C=O), 170.41 (C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C21H25N2O5: 
385.1764; found: 385.1698. 
 
N-Acetyl, (4-hydroxyphenyl)glycine cyclohexylamide 
(5a). Procedure B using tert-butyl (4-formylphenyl) 
carbonate (0.222 g, 1.000 mmol) and acetic acid was 
followed to give 5a'. 
Yield: 0.510 g (quantitative); light yellow oil.  
Rf = 0.31 (petroleum ether/diethyl ether 1:5). 
1H NMR (400 MHz, CDCl3): δ = 1.01-1.15 (m, 3H, CH2 
cyclohexyl), 1.20-1.48 (m, 3H, CH2 cyclohexyl), 1.54 [s, 
9H, C(CH3)3], 1.56-1.69 (m, 2H, CH2 cyclohexyl), 1.81-
1.93 (m, 2H, CH2 cyclohexyl), 2.08 (s, 3H, CH3CO), 
3.68-3.78 (m, 4H, NHCH + OCH3), 4.46 (d, J = 17.2 Hz, 
1H, NCH2), 4.65 (d, J = 17.2 Hz, 1H, NCH2), 5.83 (br. s, 
2H, CH + NH), 6.74 (d, J = 8.4 Hz, 2H, ArH), 6.91 (d, J 
= 8.4 Hz, 2H, ArH), 7.08 (d, J = 8.4 Hz, 2H, ArH), 7.36 
(d, J = 8.4 Hz, 2H, ArH) ppm.  
13C NMR (100.6 MHz, CDCl3): δ = 22.36 (CH3), 24.65 
(CH2), 24.71 (CH2), 25.36 (CH2), 27.58 [C(CH3)3], 32.61 
(2CH2), 48.60 (CH cyclohexyl), 50.35 (C6H4CH2), 55.13 
(OCH3), 62.04 (CH), 83.73 [C(CH3)3], 113.83 (2CH), 
121.44 (2CH), 127.32 (2CH), 129.08 (C), 130.70 (2CH), 
132.68 (C), 150.98 (C), 151.47 (C), 158.56 (C=O), 168.43 
(C=O), 172.63 (C=O) ppm. 
HRMS (ESI): m/z [M + H]+ calcd for C29H39N2O6: 
511.2808; found: 511.2796. 
Trifluoroacetic acid was added to 5a' (0.255 g, 
0.500 mmol) (0.25 M) and the solution refluxed at 80 °C 
for 10 min. TFA was then evaporated at reduced pressure 
to give 5a. 
White solid (from acetone).  
Rf = 0.78 (petroleum ether/ethyl acetate 1:4). 
M.p. 241-242 °C.  
1H NMR (400 MHz, DMSO): δ = 1.16-1.24 (m, 5H, CH2 
cyclohexyl), 1.49-1.75 (m, 5H, CH2 cyclohexyl), 1.85 (s, 
3H, CH3CO), 3.40-3.45 (m, 1H, NHCH), 5.31 (d, J = 8.4 




8.4 Hz, 2H, ArH), 7.99 (d, J = 8.0 Hz, 1H, NH), 8.29 (d, J 
= 8.4 Hz, 1H, NH), 9.34 (s, 1H, OH) ppm.  
13C NMR (100.6 MHz, DMSO): δ = 22.46 (CH3), 24.37 
(CH2), 24.49 (CH2), 25.17 (CH2), 32.18 (CH2), 32.30 
(CH2), 47.52 (CH cyclohexyl), 55.38 (CH), 114.88 
(2CH), 128.11 (2CH), 129.62 (C), 156.59 (C), 168.69 
(C=O), 169.29 (C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C16H23N2O3: 
291.1709; found: 291.1705. 
 
N-Benzyloxycarbonylglycyl, (3,4-
dihydroxyphenyl)glycine cyclohexylamide (6c). 
Procedure B using di-tert-butyl (4-formyl-1,2-phenylene) 
dicarbonate (0.338 g, 1.000 mmol) and N-
benzyloxycarbonylglycine was followed to give 6c'.  
Yield: 0.731 g (94%); light pink solid (from ethyl 
acetate/petroleum ether).  
Rf = 0.60 (petroleum ether/diethyl ether 1:5). 
M.p. 113-114 °C.  
1H NMR (400 MHz, CDCl3): δ = 1.10-1.12 (m, 3H, CH2 
cyclohexyl), 1.31-1.34 (m, 3H, CH2 cyclohexyl), 1.56 [s, 
18H, 2C(CH3)3], 1.65-1.70 (m, 2H, CH2 cyclohexyl), 1.84-
1.88 (m, 2H, CH2 cyclohexyl), 3.74-3.80 (m, 4H, OCH3 + 
CH cyclohexyl), 3.93 (br. d, J = 16.8 Hz, 1H, CH2), 4.10 
(br. d, J = 16.8 Hz, 1H, CH2), 4.43 (br. d, J = 17.2 Hz, 
1H, C6H4CH2), 4.60 (br. d, J = 17.2 Hz, 1H, C6H4CH2), 
5.10 (s, 2H, CH2 Z), 5.66 (d, J = 7.6 Hz, 1H, CH), 5.71-
5.73 (m, 2H, 2NH), 6.75 (d, J = 8.4 Hz, 2H, ArH), 6.94 (d, 
J = 8.4 Hz, 2H, ArH), 7.15 (s, 2H, ArH), 7.30-7.35 (m, 6H, 
ArH) ppm.  
13C NMR (100.6 MHz, CDCl3): δ = 24.73 (CH2), 24.81 
(CH2), 25.40 (CH2), 27.58 [2C(CH3)3], 29.63 (CH2), 31.90 
(CH2), 32.65 (CH2), 43.46 (CH2), 48.91 (CH cyclohexyl), 
49.27 (C6H4CH2), 55.17 (OCH3), 62.75 (CH), 66.85 (CH2 
Z), 84.03 [2C(CH3)3], 114.17 (CH), 123.37 (CH), 125.00 
(CH), 127.69 (CH), 127.95 (2CH), 128.03 (2CH), 128.46 
(3CH), 133.04 (C), 136.39 (C), 142.59 (C), 142.75 (C), 
150.39 (C), 150.43 (C), 156.14 (C=O), 158.91 (2C=O), 
167.37 (C=O), 170.12 (C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C42H54N3O11: 
776.3758; found: 776.3768. 
Trifluoroacetic acid was added to 6c' (0.583 g, 
0.750 mmol) (0.25 M) and the solution refluxed at 80 °C 
for 10 min. TFA was then evaporated at reduced pressure 
to give 6c. 
Yield: 0.252 g (74%); white solid (from ethyl 
acetate/diethyl ether).  
Rf = 0.82 (petroleum ether/ethyl acetate 1:4). 
M.p. 162-163 °C.  
1H NMR (400 MHz, CD3COCD3): δ = 1.11-1.71 (m, 10H, 
CH2 cyclohexyl), 3.63-3.67 (m, 1H, CH cyclohexyl), 3.87 
(d, J = 6.0 Hz, 2H, CH2), 5.10 (s, 2H, CH2 Z), 5.32 (d, J 
= 7.6 Hz, 1H, CH), 6.70 (br. d, J = 7.6 Hz, 1H, NH), 6.73 
(s, 2H, ArH), 6.91 (s, 1H, ArH), 7.26-7.39 (m, 6H, ArH + 
NH), 7.66 (d, J = 7.2 Hz, 1H, NH) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 25.62 (CH2), 
26.27 (CH2), 29.26 (CH2), 33.26 (CH2), 33.38 (CH2), 45.01 
(CH2), 49.20 (CH cyclohexyl), 57.16 (CH), 66.93 (CH2 
Z), 115.45 (CH), 115.90 (CH), 119.80 (CH), 128.63 
(2CH), 129.24 (3CH), 131.60 (C), 138.16 (C), 145.66 (C), 
145.78 (C), 157.63 (C=O), 169.13 (C=O), 170.00 (C=O) 
ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C24H30N3O6: 
456.2135; found: 456.2141. 
 
Procedure C: One-pot synthesis of N-acyl 
hydroxyphenylglycine cyclohexylamides. To a solution 
of the O-tert-butyloxycarbonylated benzaldehyde (1.00 
mmol) in ethanol/2,2,2-trifluoroethanol (1/1) (0.17  M), 
1.10 equiv of 4-methoxybenzylamine was added under a 
stream of nitrogen. After 4 hours, 1.10 equiv of the 
carboxylic acid and 1.10 equiv of cyclohexyl isocyanide 
were added and left to react for 2 days. The reaction 
mixture was then evaporated at reduced pressure and 
trifluoroacetic acid added to the residue (0.25 M). The 
solution was refluxed at 80 °C for 10 min. after which TFA 
was evaporated at reduced pressure. The product obtained 
was then recrystallized or subject to column 
chromatography 
N-Benzoyl, (4-hydroxyphenyl)glycine cyclohexylamide 
(1a). Procedure C using tert-butyl (4-formylphenyl) 
carbonate (0.222 g, 1.000 mmol) and benzoic acid was 
followed to give 1a.  
Yield: 0.221 g (63%). 
 
N-Benzoyl, (4-hydroxy-3-methoxyphenyl)glycine 
cyclohexylamide (1b). Procedure C using tert-butyl (4-
formyl-2-methoxyphenyl) carbonate (0.252 g, 
1.000 mmol) and benzoic acid was followed to give 1b. 
Yield: 0.291 g (76%); light yellow solid (from diethyl 
ether). 
Rf = 0.31 (petroleum ether/diethyl ether 1:5). 
M.p. 169-170 °C.  
1H NMR (400 MHz, CD3COCD3): δ = 1.15-1.36 (m, 5H, 
CH2 cyclohexyl), 1.57-1.91 (m, 5H, CH2 cyclohexyl), 
3.69-3.75 (m, 1H, CH cyclohexyl), 3.83 (s, 3H, OCH3), 
5.67 (s, 1H, CH), 6.81 (d, J = 8.0 Hz, 1H, ArH), 7.01 (dd, 
J = 8.0 Hz, J = 2.0 Hz, 1H, ArH), 7.19 (d, J = 2.0 Hz, 1H, 
ArH), 7.46-7.57 (m, 3H, ArH), 7.94-7.96 (m, 2H, ArH), 
8.04 (s, 1H, NH) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 25.48 (CH2), 
25.56 (CH2), 26.22 (CH2), 33.21 (CH2), 33.29 (CH2), 49.09 
(CH cyclohexyl), 56.23 (CH3), 57.60 (CH), 111.94 (CH), 
115.53 (CH), 121.15 (CH), 128.12 (2CH), 129.16 (2CH), 
131.49 (C), 132.13 (CH), 135.43 (C), 147.05 (C), 148.17 
(C), 166.46 (C=O), 170.07 (C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C22H27N2O4: 
383.1971; found: 383.1973. 
 
N-Benzoyl, (3,4-dihydroxyphenyl)glycine 
cyclohexylamide (1c). Procedure C using di-tert-butyl (4-
formyl-1,2-phenylene) dicarbonate (0.338 g, 1.000 mmol) 
and benzoic acid was followed. The residue obtained after 
removal of TFA was chromatographed through silica using 
as eluents from ethyl acetate/petroleum ether 1:3 to neat 
ethyl acetate to give 1c. 
Yield: 0.241 g (66%); white solid. 
Rf = 0.88 (petroleum ether/ethyl acetate 1:4). 




1H NMR (400 MHz, CD3COCD3): δ = 1.28-1.36 (m, 5H, 
CH2 cyclohexyl), 1.57-1.92 (m, 5H, CH2 cyclohexyl), 
3.69-3.77 (m, 1H, CH cyclohexyl), 5.59 (d, J = 7.6 Hz, 1H, 
CH), 6.80 (d, J = 8.4 Hz, 1H, ArH), 6.88 (dd, J = 8.4 Hz, 
J = 2.0 Hz, 1H, ArH), 7.04 (d, J = 2.0 Hz, 1H, ArH), 7.33 
(d, J = 7.6 Hz, 1H, C6H5CONH), 7.46-7.55 (m, 3H, ArH), 
7.90-7.97 (m, 5H, 2ArH + 2OH + NHC6H11) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 25.49 (CH2), 
25.57 (CH2), 26.22 (CH2), 33.24 (CH2), 33.32 (CH2), 49.23 
(CH cyclohexyl), 57.53 (CH), 115.58 (CH), 115.91 (CH), 
119.97 (CH), 128.07 (2CH), 129.17 (2CH), 131.73 (C), 
132.12 (CH), 135.42 (C), 145.66 (C), 145.77 (C), 166.39 
(C=O), 170.17 (C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C21H25N2O4: 
369.1814; found: 369.1811. 
 
N-(2-Naphthyl)acetyl, (3,4-dihydroxyphenyl)glycine 
cyclohexylamide (2c). Procedure C using di-tert-butyl (4-
formyl-1,2-phenylene) dicarbonate (0.338 g, 1.000 mmol) 
and 2-naphthylacetic acid was followed. The residue 
obtained after removal of TFA was dissolved in ethyl 
acetate (100 mL) and washed with KHSO4 (1 M), NaHCO3 
(1 M) and brine (3 times 25 mL each). The organic layer 
was dried with MgSO4 and the solvent evaporated at 
reduced pressure to give 2c.  
Yield: 0.338 g (78%); light yellow solid (from ethyl 
acetate/dichloromethane).  
Rf = 0.75 (petroleum ether/ethyl acetate 1:4). 
M.p. 220-221 °C.  
1H NMR (400 MHz, CD3COCD3): δ = 1.06-1.33 (m, 5H, 
CH2 cyclohexyl), 1.63-1.83 (m, 5H, CH2 cyclohexyl), 
3.59-3.66 (m, 1H, CH cyclohexyl), 3.81 [d, J = 2.8 Hz, CH2 
(2-naphthyl)acetyl], 5.38 (d, J = 8.0 Hz, 1H, CH), 6.75 (s, 
2H, ArH), 6.95 (s, 1H, ArH), 7.17 (d, J = 8.0 Hz, 1H, 
C6H3CONH), 7.46-7.53 (m, 3H, ArH), 7.70 (d, J = 7.6 Hz, 
1H, NHC6H11), 7.84-7.89 (m, 6H, ArH + 2OH) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 25.42 (CH2), 
25.52 (CH2), 26.18 (CH2), 33.19 (CH2), 33.28 (CH2), 43.57 
[CH2 (2-naphthyl)acetyl], 49.01 (CH cyclohexyl), 57.28 
(CH), 115.46 (CH), 115.84 (CH), 119.79 (CH), 126.32 
(CH), 126.80 (CH), 128.40 (2CH), 128.54 (CH), 128.59 
(CH), 128.65 (CH), 131.80 (C), 133.29 (C), 134.49 (C), 
134.85 (C), 145.57 (C), 145.74 (C), 170.04 (C=O), 170.25 
(C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C26H29N2O4: 
433.2127; found: 433.2131. 
 
N-Protocatechoyl, (4-hydroxyphenyl)glycine 
cyclohexylamide (3a). Procedure C using tert-butyl (4-
formylphenyl) carbonate (0.222 g, 1.000 mmol) and 
benzoic acid was followed. The residue obtained after 
removal of TFA was dissolved in ethyl acetate (100 mL) 
and washed with KHSO4 (1 M), NaHCO3 (1 M) and brine 
(3 times 25 mL each). The organic layer was dried with 
MgSO4 and the solvent evaporated at reduced pressure to 
give 3a. 
Yield: 0.279 g (72%). 
 
N-Protocatechoyl, (4-hydroxy-3-methoxyphenyl) 
glycine cyclohexylamide (3b). Procedure C using tert-
butyl (4-formyl-2-methoxyphenyl) carbonate (0.252 g, 
1.000 mmol) and protocatechuic acid was followed. The 
residue obtained after removal of TFA was dissolved in 
ethyl acetate (100 mL) and washed with KHSO4 (1 M), 
NaHCO3 (1 M) and brine (3 times 25 mL each). The 
organic layer was dried with MgSO4 and the solvent 
evaporated at reduced pressure to give 3b.  
Yield: 0.283 g (68%); white solid (from ethyl 
acetate/dichloromethane). 
Rf = 0.47 (petroleum ether/ethyl acetate 1:4). 
M.p. 129-130 °C.  
1H NMR (400 MHz, CD3COCD3): δ = 1.17-1.35 (m, 5H, 
CH2 cyclohexyl), 1.58-1.89 (m, 5H, CH2 cyclohexyl), 
3.68-3.73 (m, 1H, CH cyclohexyl), 3.81 (s, 3H, OCH3), 
5.63 (d, J = 7.2 Hz, 1H, CH), 6.80 (d, J = 8.0 Hz, 1H, 
ArH), 6.89 (d, J = 8.4 Hz, 1H, ArH), 6.99 (dd, J = 8.4 Hz,  
J = 2.0 Hz, 1H, ArH), 7.17 (d, J = 2.0 Hz, 1H, ArH), 7.36 
(dd, J = 8.4 Hz,  J = 2.0 Hz, 1H, ArH), 7.40 (br. s., 1H, 
NH), 7.48 (d, J = 2.0 Hz, 1H, ArH), 7.81 (d, J = 7.2 Hz, 
1H, NH) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 25.48 (CH2), 
25.56 (CH2), 26.21 (CH2), 33.24 (CH2), 33.30 (CH2), 49.20 
(CH cyclohexyl), 56.22 (CH3), 57.66 (CH), 111.91 (CH), 
115.58 (2CH), 115.62 (CH), 120.44 (CH), 121.07 (CH), 
127.15 (C), 131.70 (C), 145.63 (C), 147.05 (C), 148.16 (C), 
149.25 (C), 166.41 (C=O), 170.39 (C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C22H27N2O6: 
415.1869; found: 415.1864. 
 
N-Protocatechoyl, (3,4-dihydroxyphenyl)glycine 
cyclohexylamide (3c). Procedure C using di-tert-butyl (4-
formyl-1,2-phenylene) dicarbonate (0.338 g, 1.000 mmol) 
and protocatechuic acid was followed. The residue 
obtained after removal of TFA was chromatographed 
through silica using as eluents from ethyl 
acetate/petroleum ether 1:3 to neat ethyl acetate to give 3c.  
Yield: 0.292 g (69%); white solid (from ethyl 
acetate/dichloromethane).  
Rf = 0.41 (petroleum ether/ethyl acetate 1:4). 
M.p. 177-178 °C.  
1H NMR (400 MHz, CD3COCD3): δ = 1.21-1.33 (m, 6H, 
CH2 cyclohexyl), 1.57-1.91 (m, 4H, CH2 cyclohexyl), 
3.71-3.74 (m, 1H, CH cyclohexyl), 5.55 (d, J = 7.6 Hz, 1H, 
CH), 6.78 (d, J = 8.0 Hz, 1H, ArH), 6.85 (dd, J = 8.4 Hz, 
J = 2.0 Hz, 1H, ArH), 6.90 (d, J = 8.0 Hz, 1H, ArH), 7.03 
(d, J = 2.0 Hz, 1H, ArH), 7.35 (dd, J = 8.4 Hz, J = 2.0 Hz, 
1H, ArH), 7.48 (d, J = 2.0 Hz, 1H, ArH),  7.72 (d, J = 7.2 
Hz, 1H, C6H3CONH), 7.95 (br. s, 1H, OH), 8.08 (br. s, 1H, 
OH), 8.45 (br. s, 1H, OH), 8.49 (br. s, 1H, OH) ppm.  
13C NMR (100.6 MHz, CD3COCD3): δ = 25.49 (CH2), 
25.57 (CH2), 26.23 (CH2), 33.21 (CH2), 33.27 (CH2), 49.23 
(CH cyclohexyl), 57.35 (CH), 115.54 (CH), 115.86 (CH), 
119.84 (2CH), 120.36 (2CH), 127.07 (C), 127.10 (C), 
131.91 (C), 131.94 (C), 145.65 (C), 149.26 (C), 166.17 
(C=O), 170.34 (C=O) ppm.  
HRMS (ESI): m/z [M + Na]+ calcd for C21H24N2NaO6: 
423.1532; found: 423.1528. 
 
N-Hydrocaffeoyl, (3,4-dihydroxyphenyl)glycine 




formyl-1,2-phenylene) dicarbonate (0.338 g, 1.000 mmol) 
and hydrocaffeic acid was followed. The residue obtained 
after removal of TFA was chromatographed through silica 
using as eluents from ethyl acetate/petroleum ether 1:3 to 
neat ethyl acetate to give 4c.  
Yield: 0.317 g (74%); white solid.  
Rf = 0.45 (petroleum ether/ethyl acetate 1:4). 
M.p. 112-113 °C.  
1H NMR (400 MHz, CD3OD): δ = 1.18-1.36 (m, 6H, CH2 
cyclohexyl), 1.61-1.90 (m, 4H, CH2 cyclohexyl), 2.32-2.54 
(m, 2H, CH2), 2.72-2.77 (m, 2H, CH2), 3.72-3.88 (m, 1H, 
CH cyclohexyl), 5.23 (s, 1H, CH), 6.54 (s, 1H, ArH), 
6.64-6.68 (m, 2H, ArH), 6.74-6.68 (m, 5H, ArH), 7.02 (d, 
J = 8.4 Hz, 2H, ArH) ppm.  
13C NMR (100.6 MHz, CD3OD): δ = 26.06 (CH2), 26.12 
(CH2), 26.59 (CH2), 29.27 (CH2), 33.47 (CH2), 33.5 (CH2), 
38.28 (CH2), 49.97 (CH cyclohexyl), 58.28 (CH), 114.77 
(CH), 115.70 (CH), 116.37 (CH), 117.49 (CH), 118.69 
(CH), 120.23 (CH), 130.31 (C), 130.59 (CH), 131.47 (C), 
131.68 (C), 134.96 (C), 144.61 (C), 146.46 (C), 159.31 (C), 
171.97 (C=O), 174.80 (C=O) ppm.  
HRMS (ESI): m/z [M + H]+ calcd for C23H29N2O6: 
429.2026; found: 429.2030. 
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